Zomato CEO Deepinder Goyal has started a new venture named Continue Research by initiating a self-financed research project of 25 million dollars with the aim of going beyond food delivery and tech entrepreneurship. The project is aimed at promoting longevity research, studying the biological processes of human aging and a healthy lifespan. It is a significant change in the life of one of the most successful startup founders in India, who did not create technologies but invested in the innovation of deep science and biology.
Continue Research Fund by Deepinder Goyal is an initiative to make biology simple.
The continued research of Deepinder Goyal is based on the assumption that it might be much simpler than we have made it out to be. Goyal states that the majority of biological studies nowadays are examining issues a pixel at a time without seeing the big picture. His fund is dedicated to furthering the idea of systems-level biological research-researching how various biological processes coexist, rather than researching them separately.
Using the Continue Research Fund of $25 million, scientists and research groups around the world will be assisted in answering what any scientist or any research group is working on, which is answering easier questions than others in biology, specifically the upstream causes of aging. This involves the study of the interaction of cells, genes, and systems to determine the effect on longevity, resistance to diseases, and human performance.
Why the Zomato CEO has a 25 million Longevity Fund that is a Game Changer
Although Indian entrepreneurs have been conservative in investing in the technology startups and consumer businesses, the move by Deepinder Goyal to invest heavily in scientific research marks a new dawn in philanthro-science in India.
The majority of the science-driven projects are based on government grants or venture-capital-funded biotech startups, whereas Goyal’s fund is fully funded, and the owner is free to do long-term, high-risk, and curiosity-driven research without business considerations.
According to Goyal, the project is a multi-decadal endeavor, the mission to speed up the conscious development of humanity. His thinking is in accordance with the thinking of a contemporary entrepreneur, who will not find a value only in technology or money, but rather in resolving the deeper scientific questions, which may lead to the future of human health.
Areas of Deepinder Goyal’s Continued Research Initiative
The Continue Research program will be used to support projects that are in line with its vision of investigating the fundamental principles of human biology and longevity. Although the information regarding the initial group of the grantees is not available yet, the fund is likely to cover:
- Studies on the cell aging process and repair processes.
- Metabolic health studies and energy efficiency.
- Resilience of the immune system and cognitive aging.
- Open-source scientific models and data development.
By concentrating on basic science, but not on product creation, Goyal can hope to establish a collaborative ecosystem of world scientists, as is the case with open innovation in the software industry.
India: Implication to Startup and Research Ecosystem
The entry of Deepinder Goyal in the field of longevity research may trigger a new wave of Indian entrepreneurs to fund other areas of science and innovation, outside of commercial technology. Having already changed the online food-delivery environment in India, Goyal, as the CEO of Zomato, now hopes to invest in India with continued research to add to the up-and-coming biotech and life-science culture.
This action as well puts India on the list of those countries in the world that conduct personal longevity research, which is now dominated by tech billionaires such as Jeff Bezos (Altos Labs), Bryan Johnson (Blueprint), and Sam Altman (Retro Biosciences). There is a positive impact of Goyal’s entry on other Indian founders because it will encourage them to invest in moonshot science projects that will affect society in a long-lasting way.
Future Projections: The Future of Deepinder Goyal
Deepinder Goyal does not view Continue Research as a business but as a mission-oriented platform to redesign human biology. His vision in the long term is to simplify fundamental science and make it more open and more collaborative, as well as to foster the use of the question “why” by young researchers more frequently than “how.”
According to him, we are merely a tiny trigger in the conscious evolution of mankind.
By introducing this low-cost longevity fund of 25 million dollars, the CEO of Zomato has demonstrated that the entrepreneurial drive in India does not end with profit but ventures into the sphere of scientific interest and advancement of humanity. profit but
